The condition has put significant strain on patients and society — at a global economic cost of about $1 trillion a year, a new report estimates.
Related Posts
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income…
Senators See Possible Conflicts of Interest in Health Care Pricing Tools
The chairmen of two Senate committees overseeing health policy, concerned about companies “padding their own profits” at the expense of…
FDA Approved New Covid Shots. But Who Will Get Them?
Many older Americans, including those in nursing homes, aren’t getting booster shots.